Canopy Growth ROE 2018-2019 | CGC
Current and historical return on equity (ROE) values for Canopy Growth (CGC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Canopy Growth ROE for the three months ending September 30, 2019 was -13.44%.
| Canopy Growth ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2019-09-30 | $-1.44B | $4.26B | -29.18% |
| 2019-06-30 | $-1.42B | $4.41B | -33.49% |
| 2019-03-31 | $-0.52B | $5.52B | -15.48% |
| 2018-12-31 | $-0.32B | $5.61B | -14.36% |
| 2018-09-30 | $-0.37B | $1.41B | -35.92% |
| 2018-06-30 | $-0.11B | $0.95B | -13.79% |
| 2018-03-31 | $-0.06B | $0.97B | -7.68% |
| 2017-12-31 | $-0.02B | $0.80B | -3.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.072B | $0.170B |
| Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $148.241B | 20.46 |
| Abbott Laboratories (ABT) | United States | $147.984B | 26.99 |
| Stryker (SYK) | United States | $75.300B | 25.32 |
| Boston Scientific (BSX) | United States | $59.042B | 27.87 |
| Baxter (BAX) | United States | $41.993B | 25.46 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.354B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $29.273B | 18.36 |
| Terumo (TRUMY) | Japan | $26.625B | 33.23 |
| Coloplast (CLPBY) | Denmark | $25.164B | 40.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $24.986B | 0.00 |
| ResMed (RMD) | United States | $21.042B | 38.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.003B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $17.725B | 0.00 |
| Insulet (PODD) | United States | $10.867B | 517.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.783B | 51.75 |
| Hill-Rom Holdings (HRC) | United States | $6.911B | 20.38 |
| William Demant Holdings (WILYY) | Denmark | $6.665B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.619B | 12.34 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.420B | 0.00 |
| Haemonetics (HAE) | United States | $6.070B | 41.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.382B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| ICU Medical (ICUI) | United States | $3.829B | 24.96 |
| NuVasive (NUVA) | United States | $3.711B | 29.22 |
| Neogen (NEOG) | United States | $3.426B | 57.33 |
| Aurora Cannabis (ACB) | Canada | $3.210B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.143B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.069B | 0.00 |
| Quidel (QDEL) | United States | $2.764B | 26.23 |
| National Vision Holdings (EYE) | United States | $2.251B | 50.80 |
| Agios Pharmaceuticals (AGIO) | United States | $2.248B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.559B | 0.00 |
| InMode (INMD) | Israel | $1.492B | 0.00 |
| Aphria (APHA) | $1.245B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.148B | 23.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.950B | 17.79 |
| NanoString Technologies (NSTG) | United States | $0.887B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.790B | 19.75 |
| TG Therapeutics (TGTX) | United States | $0.780B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.743B | 28.44 |
| Omeros (OMER) | United States | $0.715B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.700B | 39.33 |
| PetIQ (PETQ) | United States | $0.672B | 16.39 |
| Quanterix (QTRX) | United States | $0.667B | 0.00 |
| HEXO (HEXO) | $0.653B | 0.00 | |
| Cerus (CERS) | United States | $0.606B | 0.00 |
| Surmodics (SRDX) | United States | $0.538B | 56.14 |
| OraSure Technologies (OSUR) | United States | $0.485B | 29.11 |
| Organigram Holdings (OGI) | Canada | $0.447B | 0.00 |
| MacroGenics (MGNX) | United States | $0.423B | 0.00 |
| Owens & Minor (OMI) | United States | $0.390B | 14.42 |
| Utah Medical Products (UTMD) | United States | $0.376B | 27.27 |
| Meridian Bioscience (VIVO) | United States | $0.375B | 12.93 |
| BioLife Solutions (BLFS) | United States | $0.337B | 137.33 |
| Zynex (ZYXI) | United States | $0.296B | 33.52 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.280B | 0.00 |
| Bovie Medical (APYX) | United States | $0.245B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.230B | 0.00 |
| United Health Products (UEEC) | United States | $0.221B | 0.00 |
| Vapotherm (VAPO) | United States | $0.220B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.159B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.154B | 774.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.153B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.136B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.135B | 0.00 |
| Female Health (VERU) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 9.18 |
| Chimerix (CMRX) | United States | $0.124B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 22.58 |
| Chembio Diagnostics (CEMI) | United States | $0.071B | 0.00 |
| Nephros (NEPH) | United States | $0.065B | 0.00 |
| Surface Oncology (SURF) | United States | $0.059B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.059B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.055B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.022B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.012B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.011B | 0.00 |
| Myomo (MYO) | United States | $0.009B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.004B | 0.00 |
